Literature DB >> 14261422

HISTOLOGICAL EFFECTS OF PROGESTINS ON HYPERPLASIA AND CARCINOMA IN SITU OF THE ENDOMETRIUM--FURTHER OBSERVATIONS.

G J STEINER, R W KISTNER, J M CRAIG.   

Abstract

Entities:  

Keywords:  DRUG THERAPY; ENDOMETRIAL HYPERPLASIA; GERIATRICS; HYDROXYPROGESTERONE; HYSTERECTOMY; MEDROXYPROGESTERONE; MENOPAUSE; MESTRANOL; NEOPLASM THERAPY; NORETHINDRONE; NORETHYNODREL; PATHOLOGY; PROGESTATIONAL HORMONES; UTERINE NEOPLASMS

Mesh：

Substances：

Year:  1963        PMID： 14261422     DOI： 10.1016/0026-0495(65)90024-7

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  5 in total

Review 1.  Cancer in Jews: introduction and overview.

Authors:  Henry T Lynch; Wendy S Rubinstein; Gershon Y Locker
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

2.  Effect of cyproterone acetate, levonorgestrel and progesterone on adrenal glands and reproductive organs in the beagle bitch.

Authors:  M F El Etreby
Journal:  Cell Tissue Res       Date:  1979-08       Impact factor: 5.249

3.  [Effect of gestagen therapy upon estradiol- and progesterone-receptor-level and 17beta-hydroxysteroid dehydrogenase in human endometrial adenocarcinoma (author's transl)].

Authors:  K Pollow; E Boquoi
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-08-30

4.  Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study.

Authors:  Umberto Leone Roberti Maggiore; Fabio Martinelli; Giulia Dondi; Giorgio Bogani; Valentina Chiappa; Maria Teresa Evangelista; Viola Liberale; Antonino Ditto; Simone Ferrero; Francesco Raspagliesi
Journal:  J Gynecol Oncol       Date:  2019-02-26       Impact factor: 4.401

5.  Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers.

Authors:  Oluwole Fadare; Wenxin Zheng
Journal:  Diagn Pathol       Date:  2008-02-08       Impact factor: 2.644
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.